Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02624739 · ClinicalTrials.gov registry record · NA

Reassure Remote Respiration Monitoring in Heart Failure Patients

A NA study, sponsored by ResMed.

Terminated
Registry status
NA
Development phase
17
Enrollment target

NCT02624739: Clinical Trial NA study, sponsored by ResMed.

NCT02624739 is a NA study that was terminated before completion, run by ResMed. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02624739, a NA study, was terminated before completion, sponsored by ResMed.

TERMINATED
Registry status
NA
Development phase
17 participants
Enrollment target

Study Summary

This study is designed to descriptively assess improvement in quality of life and test the usability of remotely monitored respiration parameters in the routine management of recently discharged heart failure patients. It will consist of two arms: (i) intervention, and (ii) control. Participants will be randomized to either arm at time of enrollment. Every participant enrolled in the study will receive a device for remote monitoring.

Primary Outcome

Number of successful data transmissions compared to number of possible data transmissions

Interventions

  • DEVICE Reassure Non-Contact Respiration Monitor

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2015-12
Est. Completion 2016-07
Phase NA
ResMed

25 total trials

Why NCT02624739 stopped before completion

NCT02624739 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Reassure Non-Contact Respiration Monitor is the first listed.

NCT02624739 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02624739 about?

NCT02624739 is a clinical study titled "Reassure Remote Respiration Monitoring in Heart Failure Patients". This study is designed to descriptively assess improvement in quality of life and test the usability of remotely monitored respiration parameters in the routine management of recently discharged heart failure patients. It will consist of two arms: (i) intervention, and (ii) control. Participants wil...

What is the current status of trial NCT02624739?

This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2015-12. Estimated completion is 2016-07.

What interventions are being tested in trial NCT02624739?

The interventions under investigation include: Reassure Non-Contact Respiration Monitor (DEVICE).

Who is sponsoring clinical trial NCT02624739?

This trial is sponsored by ResMed, which has 25 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02624739's enrollment target sits among peer trials

17 1871st of 2000 higher than 130 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02624739, the US trial registry maintained by the National Library of Medicine. NCT02624739 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.